AH Calvert
Impact in
- Otorhinolaryngology top 10%
- Head and Neck Cancer Studies
-
- Colorectal Cancer Treatments and Studies
- Cancer-related Molecular Pathways
- PARP inhibition in cancer therapy
Papers in
-
- Biochemical and Molecular Research 4
- Oncology 9
- Cancer Treatment and Pharmacology 4
- Co-authors
- KR Harrap (4 shared papers)Ann L. Jackman (3 shared papers)DR Newell (2 shared papers)L A Price (1 shared paper)Graham M. F. Bisset (2 shared papers)Leslie R. Hughes (2 shared papers)David R. Newell (3 shared papers)Mark R. Middleton (1 shared paper)
- Journals
- Journal of Clinical Oncology (3 papers)Journal of Medicinal Chemistry (3 papers)European Journal of Cancer (2 papers)Clinical Cancer Research (1 paper)Investigational New Drugs (1 paper)
- Partner nations
- United KingdomItalyCanada
In The Last Decade
AH Calvert
29 papers receiving 315 citations
Peers
Comparison fields: 5 of 63
- Otorhinolaryngology 28
- Oncology 161
- Organic Chemistry 86
- Molecular Biology 171
- Genetics 21
Countries citing papers authored by AH Calvert
This map shows the geographic impact of AH Calvert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by AH Calvert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites AH Calvert more than expected).
Fields of papers citing papers by AH Calvert
This network shows the impact of papers produced by AH Calvert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by AH Calvert. The network helps show where AH Calvert may publish in the future.
Co-authors
The 25 scholars most cited alongside AH Calvert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 63 | |
| 2 | 1975 | 41 | |
| 3 | 2005 | 37 | |
| 4 | 1983 | 36 | |
| 5 | 1995 | 27 | |
| 6 | 1992 | 25 | |
| 7 | Pharmacokinetics of the thymidylate synthase inhibitor N10-propargyl-5,8-dideazafolic acid (CB3717) in the mouse. | 1986 | 22 |
| 8 | 1990 | 16 | |
| 9 | 2006 | 13 | |
| 10 | Combined results of 4 phase I and pharmacokinetic (PK) studies of E7070, a novel chloroindolyl-sulphonamide inhibiting the activation of cdk2 and cyclin E | 2000 | 7 |
| 11 | A phase I study of a novel, trinuclear, platinum analogue, BBR3464, in patients with advanced solid tumors | 1999 | 7 |
| 12 | Phase 1 pharmacokinetic (PK) study of CT-2103 given Q2 or Q3 weeks in patients with solid tumors | 2003 | 6 |
| 13 | Recent preclinical and clinical studies with the thymidylate synthase inhibitor N10-propargyl-5,8-dideazafolic acid (CB3717) | 1987 | 5 |
| 14 | 1993 | 4 | |
| 15 | A PHASE-I HIGH-DOSE ESCALATION STUDY OF CARBOPLATIN | 1987 | 3 |
| 16 | 1986 | 3 | |
| 17 | Mortality in protein calorie malnutrition. | 1972 | 3 |
| 18 | 2-AMINO-4-HYDROXY QUINAZOLINES WITH DUAL METABOLIC LOCI IN METHOTREXATE RESISTANT CELLS | 1979 | 2 |
| 19 | IMPROVED RESULTS IN COMBINATION CHEMOTHERAPY OF HEAD AND NECK CANCER | 1977 | 2 |
| 20 | PHARMACOLOGICAL STUDIES WITH THE ANTHRAPYRAZOLE CI 941 - A NEW DNA COMPLEXING DRUG | 1986 | 2 |
About AH Calvert
AH Calvert is a scholar working on Molecular Biology, Oncology, Organic Chemistry, General Health Professions and Philosophy, having authored 32 papers that have together received 336 indexed citations. Recurring topics across this work include Health, Medicine and Society (7 papers), Aging, Elder Care, and Social Issues (7 papers), Hermeneutics and Narrative Identity (7 papers), Quinazolinone synthesis and applications (6 papers), Cancer Treatment and Pharmacology (4 papers), Biochemical and Molecular Research (4 papers), Synthesis and Characterization of Heterocyclic Compounds (4 papers) and Computational Drug Discovery Methods (2 papers). The work is most often cited by research in Otorhinolaryngology (28 citations), Oncology (161 citations), Organic Chemistry (86 citations), Molecular Biology (171 citations) and Genetics (21 citations). AH Calvert has collaborated with scholars based in United Kingdom, Italy and Canada. Frequent co-authors include KR Harrap, Ann L. Jackman, DR Newell, L A Price, Graham M. F. Bisset, Leslie R. Hughes, David R. Newell, Mark R. Middleton, Kerry L. Sayle and Steven D. Reich. Their work appears in journals such as Journal of Clinical Oncology, Journal of Medicinal Chemistry, European Journal of Cancer, Clinical Cancer Research and Investigational New Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.